Free tool
Cell therapy stocks
We cover 67 companies grouped under the Cell therapy theme. The median market value in the group is $59.45M. Across the group, the median move over the past trading day is −0.52%. 38% of the 66 with a 200-day average trade above it. Price change over the past year runs from −63.3% to +75.3% across the middle 80 percent of the group, with a median of −22.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
67 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LEGN | Legend Biotech Corporation | $20.68 | +8.61% | −3.86% | −40.44% |
| IOVA | Iovance Biotherapeutics, Inc. | $8.08 | +71.91% | +220.63% | +233.88% |
| MSB.AX | Mesoblast Limited | 2.45 AUD | +19.85% | −11.73% | +1.03% |
| MESO | Mesoblast Limited | $16.84 | +16.54% | −7.27% | +4.47% |
| VCEL | Vericel Corporation | $42.44 | −9.14% | +19.18% | +18.25% |
| VOR | Vor Biopharma Inc. | $23.67 | +18.35% | +103.35% | −40.82% |
| SANA | Sana Biotechnology, Inc. | $4.16 | +26.44% | −0.72% | +23.44% |
| ALLO | Allogene Therapeutics, Inc. | $2.04 | +22.89% | +51.11% | +75.86% |
| PROK | ProKidney Corp. | $1.74 | +12.99% | −21.97% | −30.12% |
| AUTL | Autolus Therapeutics plc | $2.33 | +60.69% | +24.60% | +48.41% |
| ARTV | Artiva Biotherapeutics, Inc. | $11.77 | +11.78% | +178.25% | +259.94% |
| KYTX | Kyverna Therapeutics, Inc. | $8.61 | +14.95% | −1.82% | +133.33% |
| CABA | Cabaletta Bio, Inc. | $3.25 | +19.05% | +47.06% | +116.67% |
| 4592.T | SanBio Company Limited | 997.00 JPY | +10.78% | −39.10% | −57.08% |
| CAPR | Capricor Therapeutics, Inc. | $9.36 | +42.47% | −66.94% | +49.76% |
| 005690.KS | Pharmicell Co., Ltd. | 10,850.00 KRW | +20.82% | −24.76% | −0.03% |
| IPSC | Century Therapeutics, Inc. | $2.14 | +4.39% | +115.08% | +315.53% |
| LYEL | Lyell Immunopharma, Inc. | $15.49 | +19.25% | −46.55% | +37.32% |
| ALCLS.PA | Cellectis S.A. | 2.94 EUR | +16.59% | −30.30% | +27.74% |
| CLLS | Cellectis S.A. | $3.42 | +20.42% | −28.75% | +28.09% |
| RNAC | Cartesian Therapeutics, Inc. | $10.19 | +33.20% | +50.74% | −4.09% |
| FATE | Fate Therapeutics, Inc. Common Stock | $2.57 | +10.78% | +159.60% | +129.46% |
| 4894.T | Cuorips Inc. | 5,720.00 JPY | +35.06% | −8.04% | −15.38% |
| LCTX | Lineage Cell Therapeutics, Inc. | $1.12 | +4.67% | −31.71% | −8.20% |
| 4593.T | Healios K.K. | 286.00 JPY | +34.91% | +1.78% | −41.63% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | 847.00 JPY | +40.00% | +44.79% | +75.00% |
| NKTX | Nkarta, Inc. | $2.63 | +18.47% | +40.64% | +17.41% |
| 504A.T | Innovacell Inc. | 570.00 JPY | +3.07% | −45.71% | −45.71% |
| OCC.AX | Orthocell Limited | 0.76 AUD | +6.29% | −32.14% | −36.67% |
| MXCT | MaxCyte, Inc. | $1.31 | +24.76% | −15.48% | −6.43% |
| ATRA | Atara Biotherapeutics, Inc. | $9.38 | +20.10% | −47.21% | −24.05% |
| ACET | Adicet Bio, Inc. | $8.95 | +9.15% | +1.47% | −26.01% |
| INKT | MiNK Therapeutics, Inc. | $11.79 | +11.86% | +6.03% | −26.22% |
| V3V.DE | FamiCord AG | 2.86 EUR | +0.70% | −52.73% | −61.35% |
| 7776.T | CellSeed Inc. | 232.00 JPY | +15.42% | −16.85% | −47.39% |
| 4896.T | K Pharma,Inc. | 763.00 JPY | +6.71% | +13.88% | +14.56% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 588.00 GBP | −8.12% | +3.52% | +70.43% |
| ALA.AX | Arovella Therapeutics Limited | 0.06 AUD | −1.59% | −33.33% | −30.34% |
| TCRX | TScan Therapeutics, Inc. | $0.78 | +0.44% | −23.78% | −58.43% |
| 7096.T | StemCell Institute Inc. | 762.00 JPY | +6.87% | −3.30% | −22.80% |
| 2370.T | MEDINET Co., Ltd. | 26.00 JPY | 0.00% | −10.34% | −33.33% |
| TVGN | Tevogen Inc. | $6.70 | +19.86% | −63.19% | −85.43% |
| 3750.T | ADR Biomedical Holdings Inc. | 785.00 JPY | +0.26% | −8.08% | −14.11% |
| 4880.T | CellSource Co., Ltd. | 345.00 JPY | +9.87% | −13.75% | −42.78% |
| 4893.T | Noile-Immune Biotech Inc. | 148.00 JPY | +11.28% | +10.45% | −16.38% |
| 4892.T | Cyfuse Biomedical K.K. | 566.00 JPY | +14.34% | −6.75% | −9.00% |
| PTG.WA | Poltreg S.A. | 25.00 PLN | +9.17% | −1.96% | −14.68% |
| CCEL | Cryo-Cell International, Inc. | $4.25 | +25.74% | +23.91% | −3.19% |
| ESLA | Estrella Immunopharma, Inc. | $0.73 | −2.54% | −47.48% | −22.34% |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% |
| SVA.TO | Sernova Biotherapeutics Inc | 0.11 CAD | −8.33% | −15.38% | −42.11% |
| LGVN | Longeveron Inc. | $0.70 | +17.02% | +18.60% | −14.44% |
| NCEL | NewcelX Ltd. | $3.38 | −2.87% | +61.72% | −84.77% |
| PLUR | Pluri Inc. | $1.48 | −11.90% | −50.50% | −69.17% |
| SNTI | Senti Biosciences Holdings, Inc. | $0.39 | +1.15% | −64.87% | −75.23% |
| INAB | IN8bio, Inc. | $1.19 | +6.76% | −51.83% | −48.03% |
| GDTC | CytoMed Therapeutics Limited | $1.00 | +10.13% | −28.29% | −50.41% |
| F98.F | CytoMed Therapeutics Limited | 0.84 EUR | +12.08% | −73.06% | −50.30% |
| CMB.AX | Cambium Bio Limited | 0.42 AUD | −2.33% | −9.68% | −4.55% |
| CELZ | Creative Medical Technology Holdings, Inc. | $1.19 | +61.60% | −39.59% | −63.27% |
| 1AD.AX | AdAlta Limited | 0.00 AUD | −25.00% | −25.00% | −25.00% |
| PMCB | PharmaCyte Biotech, Inc. | $0.54 | −8.39% | −26.76% | −44.28% |
| ERNA | Ernexa Therapeutics Inc. | $4.89 | +35.46% | −83.14% | −85.93% |
| BRTX | BioRestorative Therapies, Inc. | $0.22 | −18.64% | −82.22% | −86.10% |
| MBIO | Mustang Bio, Inc. | $0.56 | −11.25% | −47.66% | −63.40% |
| BSFA.L | BSF Enterprise Plc | 1.15 GBP | +43.75% | −39.47% | −48.89% |
| CRBU | Caribou Biosciences, Inc. | $1.65 | +10.74% | +3.77% | −16.67% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.